Related Topics
 

Chemical Biology & Therapeutics



The Chemical Biology and Therapeutics Department at St. Jude was established to facilitate discovery of new bioactive small molecules and to bridge the gap between the identification of newly discovered active compounds with modest efficacy and potency to highly active compounds that can be used as pharmacological tools or preclinical leads. Its mission is to discover and develop novel chemical entities that increase understanding of the pathophysiology of or function as therapeutic leads for the treatment of catastrophic pediatric illnesses.

The department applies state-of-the-art high throughput techniques used for industrial discovery and development of drugs to the discovery of pharmacological tools and drug candidates for catastrophic pediatric disease. St. Jude is currently recruiting scientists with significant experience in drug development to build a pipeline that runs from discovery biology laboratories at St. Jude through high throughput chemistry and screening facilities to lead development groups within the department. The output of the program will include unique tools for the study of disease, novel methods for drug discovery, and therapeutic lead compounds. 

Kip Guy, PhD, one of the nation’s leading experts in chemical biology and synthetic organic chemistry, leads the new department. As chair, he is a key investigator in efforts to identify molecules that hold promise as tools for studying childhood cancers and synthesizing novel molecules designed to offer more effective and less toxic treatments than are currently available.


Email This Article Email This Article   |   Print Print